Purchase Order 75F40126P00037
Award Date 4/28/26
Potential Completion Date 9/30/26
Potential Value $134K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80301, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Indevr, Inc., a manufacturer of goods and provider of analytical technologies, for a Multiplex Microarray Assay Imaging System. The contract, valued at $84,895.00, will be performed in Boulder, Colorado and has a completion date of June 1, 2024. Indevr, a for-profit organization, has provided similar...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Indevr, Inc., a for-profit manufacturer of goods and provider of progressive analytical technologies. The $195,200.00 contract is for the delivery of 2 VIRUS COUNTERS MACHINES - MODEL VIROCYT2100. This award has a total small business set aside designation. Indevr, Inc. has previously held other federal contracts and grants with agencies including the National Institutes of Health's National Institute...
- The Department of Health and Human Services Food and Drug Administration awarded a $25,000 purchase order to Integra Biosciences Corp. of Hudson, New Hampshire for a digital microfluidic platform. The firm fixed price contract runs from September 11, 2023 through October 17, 2023 and has a total small business set aside designation. Integra Biosciences will provide the FDA with equipment and services to support its regulatory review and approval processes for medical devices and other products...
- The Food and Drug Administration (FDA) awarded a $947,868.05 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for the delivery of a high-resolution ion mobility-high resolution mass spectrometer (HRIM-HRMS) system. This system will expand the FDA's analytical capabilities for ensuring the safety and efficacy of complex drugs like biologics, peptides, and oligonucleotides. The contract has a completion date of January 31, 2024 and includes training,...
- Pacific Biosciences of California, Inc., a small business biotechnology firm specializing in long-read DNA and RNA sequencing technologies, received a $726,318.04 firm fixed-price purchase order from the Food and Drug Administration on September 28, 2023. The award covers a Sequel IIE long-read DNA/RNA sequencer system and associated consumables to support the National Antimicrobial Resistance Monitoring System. The contract, designated as a total small business set-aside, includes performance...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The award, worth $205,330.37, is for the supply of Illumina reagent chemistry kits to the Food and Drug Administration (FDA), a civilian agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of September 30, 2024. The contract does not have a set-aside designation, reflecting Illumina's specialized...
- The U.S. Food and Drug Administration awarded a Firm Fixed Price Purchase Order contract to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of PacBio Revio sequencing reagent kits or equal products. The $48,715.20 contract has a completion date of September 30, 2024 and will support research at the FDA's National Center for Toxicological Research. This award is associated with a larger $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ)...
- This is a firm fixed-price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Indevr, Inc., a for-profit manufacturer of goods. The contract, valued at $650,000.00, is for the provision of reagents and kits with a period of performance through May 4, 2020. Indevr has previously been awarded other federal contracts for the supply of analytical technologies to support vaccine research and development, including multiplex microarray assay platforms, automated...
- The Food and Drug Administration awarded a $14,070 firm fixed-price purchase order to Illumina, Inc. for a service contract related to a MiSeq instrument on June 24, 2021, with completion targeted for June 29, 2023. The contract was issued without a small business set-aside designation, despite originating from a total small business solicitation posted on May 18, 2021. Performance of services will take place in Winchester, Massachusetts. Illumina, a San Diego-based biotechnology company...
- This is a firm fixed-price delivery order for $39,982.41 awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis technologies. The contract provides Illumina reagent chemistry kits to support the agency's scientific research and diagnostic applications. This award is part of a larger $45 million Indefinite Delivery Contract the company holds with the U.S. Department of Agriculture (USDA) as well...